Animal experiments on bowel cancer have been completed, and clinical trials are now being filed, which involves a lot of things, including various confidentiality agreements and patent applications.

This time, the research found that no matter who it is, it is not a trivial matter, whether it is Bona or Kangxidin, or Bai Ye and Liu Yue, this is a subject experiment full of expectations for each of them.

Because once this can be proven in clinical trials, then it is definitely a big deal for the development history of bowel cancer.

This time is different from the last time, after the problem of cobalt-chromium alloy, everyone does not use this substance at most, there are other equipment that can be used, and even this disease, even if it is not used, it doesn't matter, this is not a fatal disease at all, but intestinal cancer is different, this is a serious life-threatening problem.

Therefore, the gap between the two is still clear at a glance.

After the establishment of the clinical trial base, this is the first time that Puze Hospital has undertaken such an international clinical trial task, although the domestic clinical trial is basically not much different from the world standard, but the only thing is to grasp the accuracy is a very important problem.

Accuracy is precision, which mainly includes the identification of observation data, observation indicators and influencing factors in the test.

On the day when the clinical trial base began, Puze came to a lot of reporters.

Harvard's clinical trials, which countless countries are rushing to do, because they can learn a lot of things, especially in scientific research.

For Puze to be able to win such a task, this made countless hospitals envious, but when they learned that Bai Ye was the person in charge of the research group, they were silent.

This is Bai Ye's alma mater, and he brought a team to his hospital to do scientific research, and it seems that there is nothing wrong with it, right?

All the media are very curious about what is the main direction of this project, and where is the progress of the research, and what is the main purpose of this clinical trial?

In this regard, Bai Ye, Bona and others did not hide it, rather than letting everyone speculate, it was better to announce it openly.

Therefore, before the clinical trial was launched, the team held an academic conference, and the organizer was the Bai Ye Research Institute...... He's really short of money!

But for this little money, Bai Ye still has no shortage of money, and the cost of a conference does not need to find any pharmaceutical companies to sponsor and support at all.

After all, the Bai Ye Research Institute and the Balance Group are also the leaders in the field of medicine in Kyoto, and more and more cooperation and investment have come to the door, the scale of the Bai Ye Research Institute has long been completely different from the beginning, after two years have passed, the scale of the Bai Ye Research Institute has expanded several times, and the construction project of the school is close to completion, and it will soon be put into use.

This meeting was not originally hyped, but Bai Ye still underestimated the strength of this team, and in just one day, the news of the meeting spread throughout the industry.

The circle is not big, but it is not small, and there are only a few companies engaged in cancer research and development that can be said to be famous, and they suddenly focus on this one by one.

Pfizer, Novartis, Johnson & Johnson, Roche and many other industry leaders have begun to dispatch and send the company's senior management to pay close attention to this matter.

This is all a big deal in the medical industry, especially Pfizer, whose research progress in the field of oncology has exceeded many people's imagination, they have never relaxed, and even for Bona and others, they have always sponsored it.

In the latest research report last year, Pfizer topped the list with annual sales of $82.7 billion, profits of $41.7 billion, assets of $264.6 billion, and market value of $307.7 billion, which is the only pharmaceutical company in the pharmaceutical industry to enter the top ten in the world economy.

Rich is the most appropriate adjective!

Fino Group and SPOM Group are both top 100 enterprises, as well as Johnson & Johnson, they are good at different fields, Johnson & Johnson's auxiliary tools and instruments, SPOM inspection, Feinuo's implantable materials, etc., are the soul of each enterprise, each with its own bias.

But the market for oncology is so big that everyone wants a piece of the pie, and most importantly, so far, this patent is still in the hands of scientists, not capitalists, which means that they can buy it.

It saves a lot of money and time for scientific research.

Even if it is a one-shot deal, it can make a lot of money.

When all this was planned, many students from Puze came to help, after all, this conference was nominally a meeting held by the Puze Institute of Traditional Chinese and Western Medicine and Harvard Medical School.

Puze Hospital is affiliated to the Puze Institute of Traditional Chinese and Western Medicine, in fact, this is a unit, but when it comes to clinical practice, it is called Puze Hospital, but when it comes to scientific research and enrollment, it is called Puze Institute of Traditional Chinese and Western Medicine.

This conference is one of the few high-level international conferences in China, and there is no invitation letter for this meeting, only an application letter, and only after the application has passed the review, you can come to participate.

The name of the conference was resounding: "The 1st World Summit Forum on Oncology Research!"

It seems that Bai Ye did it intentionally, but the establishment of the first World Oncology Summit Forum means that when it is held again in the future, there will be a second and third ......

Bai Ye did this deliberately, because he wanted to set up an organization, this idea he had been planning for a while, he wanted to expand the tumor research project, it was not just as simple as bowel cancer, he wanted to set up such an organization, so that people who were willing to join it to join it, research and work together.

During this time at Harvard, Bai Ye has fully realized the shortcomings of a person, his ability is really limited, and the strength of many people is great, without the help of Bona and Conxitin, it is impossible to study it so quickly.

Since it is necessary to drive, it is necessary to drive purposefully, and tumor is a good method. Because of the disease of tumor, he involves various departments, and it is not so much that tumor is a disease, but that tumor is a pathological state of the whole system.

The classification of tumors is too broad, lung cancer, intestinal cancer, liver cancer, kidney cancer, brain cancer, cervical cancer, ...... And so on, as if tumors can do anything.

Therefore, Bai Ye made a decision after thinking about it, since this is the case, it is better to directly let Harvard Medical School and Puze Hospital cooperate in the construction of the project, and carry out classified development for tumors, this form seems to be more convenient than others.

Because, to be honest, let Harvard Medical School simply cooperate with Puze in all departments, to be honest, they may not really have much care, but the tumor is different, because Bai Ye can take the lead, everything is very convenient.

Besides, simply helping Puze is a bit too limited, there are so many talents in China, how many people are there in Puze?

After the establishment of a cooperative unit, it is difficult for talents from other units to join it, but the establishment of the Summit Forum is different, this is an academic organization, does not contain so many complex rules and regulations, and is more conducive to many people to join.

The more Bai Ye thought about it, the more he felt that this matter was promising, Harvard was a big tree, but there were so many talents in the world, why not let them all join it?

…………